Top

Annals of Surgical Oncology

Published in:

01-04-2006

Recurrence After Cystectomy for Borderline Ovarian Tumors: Results of a French Multicenter Study

Authors: Christophe Poncelet, MD, PhD, Raffaèle Fauvet, MD, Joëlle Boccara, MD, Emile Daraï, MD, PhD

Published in: Annals of Surgical Oncology | Issue 4/2006

Abstract

Background

Fertility-sparing surgery for borderline ovarian tumors (BOT) is feasible and effective and does not seem to have a negative effect on survival. Specific data on the effect of cystectomy, and notably on recurrence, are lacking.

Methods

This was a French retrospective multicenter study of 313 women with stage I BOT treated from 1990 to 2000 in 13 specialized gynecological units and 1 cancer center. Diagnosis and staging were based on International Federation of Gynecology and Obstetrics (1989) criteria. Surgery consisted of cystectomy, unilateral salpingo-oophorectomy (USO), or bilateral salpingo-oophorectomy (BSO).

Results

After cystectomy, persistent BOT and benign ovarian cysts on the operated ovary were observed in 15% and 65% of patients, respectively. Mean follow-up did not differ among patients receiving the three types of surgery. The recurrences after cystectomy, USO, and BSO treatment were 30.3%, 11%, and 1.7%, respectively (P < .0001). Recurrences were more frequent after cystectomy than after USO (P = .0001) and BSO (P = .0001) and when intraoperative cyst rupture occurred (P = .04).

Conclusions

These results suggest that cystectomy for BOT is associated with a high risk of intraoperative cyst rupture and of recurrence compared with USO or BSO.

International Federation of Gynecology and Obstetrics. Classification and staging of malignant tumors in the female pelvis. Acta Obstet Gynecol Scand 1971;50:1–7

Scully RE. World Health Organization classification and nomenclature of ovarian cancer. Natl Cancer Inst Monogr 1975;42:5–7PubMed

Bostwick DG, Tazelaar HD, Ballon SC, Hendrickson MR, Kempson RL. Ovarian epithelial tumors of borderline malignancy. A clinical and pathologic study of 109 cases. Cancer 1986;58:2052–65PubMed

International Federation of Gynaecoloy and Obstetrics. Annual report and results of treatment in gynaecologic cancer. Int J Gynaecol Obstet 1989;28:189–90

Rota SM, Zanetta G, Ieda N, et al. Clinical relevance of retroperitoneal involvement from epithelial ovarian tumors of borderline malignancy. Int J Gynecol Cancer 1999;9:477–80CrossRefPubMed

Gotlieb WH, Flikker S, Davidson B, Korach Y, Kopolovic J, Ben-Baruch G. Borderline tumors of the ovary: fertility treatment, conservative management, and pregnancy outcome. Cancer 1998;82:141–6CrossRefPubMed

Seidman JD, Kurman RJ. Ovarian serous borderline tumors: a critical review of the literature with emphasis on prognostic indicators. Hum Pathol 2000;31:539–57CrossRefPubMed

Seracchioli R, Venturoli S, Colombo FM, Govoni F, Missiroli S, Bagnoli A. Fertility and tumor recurrence rate after conservative laparoscopic management of young women with early-stage borderline ovarian tumors. Fertil Steril 2001;76:999–1004CrossRefPubMed

Donnez J, Bassil S. Indications for cryopreservation of ovarian tissue. Hum Reprod Update 1998;4:248–59CrossRefPubMed

10.

Donnez J, Munschke A, Berliere M, et al. Safety of conservative management and fertility outcome in women with borderline tumors of the ovary. Fertil Steril 2003;79:1216–21PubMed

11.

Camatte S, Morice P, Pautier P, Atallah D, Duvillard P, Castaigne D. Fertility results after conservative treatment of advanced stage serous borderline tumour of the ovary. BJOG 2002;109:376–80PubMed

12.

Crispens MA. Borderline ovarian tumours: a review of the recent literature. Curr Opin Obstet Gynecol 2003;15:39–43CrossRefPubMed

13.

Morice P, Camatte S, El Hassan J, Pautier P, Duvillard P, Castaigne D. Clinical outcomes and fertility after conservative treatment of ovarian borderline tumors. Fertil Steril 2001;75:92–6CrossRefPubMed

14.

Morice P, Camatte S, Wicart-Poque F, et al. Results of conservative management of epithelial malignant and borderline ovarian tumours. Hum Reprod Update 2003;9:185–92CrossRefPubMed

15.

Tazelaar HD, Bostwick DG, Ballon SC, Hendrickson MR, Kempson RL. Conservative treatment of borderline ovarian tumors. Obstet Gynecol 1985;66:417–22PubMed

16.

Lim-Tan SK, Cajigas HE, Scully RE. Ovarian cystectomy for serous borderline tumors: a follow-up study of 35 cases. Obstet Gynecol 1988;72:775–81PubMed

17.

Barnhill DR, Kurman RJ, Brady MF, et al. Preliminary analysis of the behavior of stage I ovarian serous tumors of low malignant potential: a Gynecologic Oncology Group study. J Clin Oncol 1995;13:2752–6PubMed

18.

Zanetta G, Chiari S, Rota S, et al. Conservative surgery for stage I ovarian carcinoma in women of childbearing age. BJOG 1997;104:1030–5

19.

Darai E, Teboul J, Fauconnier A, Scoazec JY, Benifla JL, Madelenat P. Management and outcome of borderline ovarian tumors incidentally discovered at or after laparoscopy. Acta Obstet Gynecol Scand 1998;77:451–7CrossRefPubMed

20.

Kaern J, Trope CG, Abeler VM. A retrospective study of 370 borderline tumors of the ovary treated at the Norwegian Radium Hospital from 1970 to 1982. A review of clinicopathologic features and treatment modalities. Cancer 1993;71:1810–20PubMed

21.

Zanetta G, Rota S, Chiari S, Bonazzi C, Bratina G, Mangioni C. Behavior of borderline tumors with particular interest to persistence, recurrence, and progression to invasive carcinoma: a prospective study. J Clin Oncol 2001;19:2658–64.PubMed

22.

Trope CG, Kristensen G, Makar A. Surgery for borderline tumor of the ovary. Semin Surg Oncol 2000;19:69–75PubMed

23.

Lin PS, Gershenson DM, Bevers MW, Lucas KR, Burke TW, Silva EG. The current status of surgical staging of surgical staging of ovarian serous borderline tumors. Cancer 1999;85:905–11PubMed

24.

Darai E, Teboul J, Walker F, et al. Epithelial ovarian carcinoma of low malignant potential. Eur J Obstet Gynecol Reprod Biol 1996;66:141–5CrossRefPubMed

25.

Gershenson DM. Contemporary treatment of borderline ovarian tumors. Cancer Invest 1999;17:206–10PubMed

26.

Candiani M, Vasile C, Sgherzi MR, Nozza A, Maggi F, Maggi R. Borderline ovarian tumors: laparoscopic treatment. Clin Exp Obstet Gynecol 1999;26:39–43PubMed

27.

Winter WE III, Kucera PR, Rodgers W, McBroom JW, Olsen C, Maxwell GL. Surgical staging in patients with ovarian tumors of low malignant potential. Obstet Gynecol 2002;100:671–6CrossRefPubMed

28.

Querleu D, Papageorgiou T, Lambaudie E, Sonoda Y, Narducci F, LeBlanc E. Laparoscopic restaging of borderline ovarian tumours: results of 30 cases initially presumed as stage IA borderline ovarian tumours. BJOG 2003;110:201–4PubMed

29.

Trimble EL, Trimble LC. Epithelial ovarian tumors of low malignant potential. In: Markman M, Hoskins WJ, eds. Cancer of the Ovary. New York: Raven Press, 1993:415–29

30.

Fauvet R, Boccara J, Dufournet C, David-Montefiore E, Poncelet C, Darai E. Restaging surgery for women with borderline ovarian tumors: results of a French multicenter study. Cancer 2004;100:1145–51CrossRefPubMed

31.

Fauvet R, Poncelet C, Boccara J, Descamps P, Fondrinier E, Darai E. Fertility after conservative treatment for borderline ovarian tumors: a French multicenter study. Fertil Steril 2005; 83:284–90CrossRefPubMed

32.

Havrilesky LJ, Peterson BL, Dryden DK, Soper JT, Clarke-Pearson DL, Berchuck A. Predictors of clinical outcomes in the laparoscopic management of adnexal masses. Obstet Gynecol 2003;102:243–51CrossRefPubMed

33.

Vergote I, De Brabanter J, Fyles A, et al. Prognostic importance of degree of differentiation and cyst rupture in stage I invasive epithelial ovarian carcinoma. Lancet 2001;357:176–82CrossRefPubMed

Title: Recurrence After Cystectomy for Borderline Ovarian Tumors: Results of a French Multicenter Study
Authors: Christophe Poncelet, MD, PhD
Raffaèle Fauvet, MD
Joëlle Boccara, MD
Emile Daraï, MD, PhD
Publication date: 01-04-2006
Publisher: Springer-Verlag
Published in: Annals of Surgical Oncology / Issue 4/2006
Print ISSN: 1068-9265
Electronic ISSN: 1534-4681
DOI: https://doi.org/10.1245/ASO.2006.12.024

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Recurrence After Cystectomy for Borderline Ovarian Tumors: Results of a French Multicenter Study

Abstract

Background

Methods

Results

Conclusions

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Abstract

Background

Methods

Results

Conclusions

Please log in to get access to this content

Other articles of this Issue 4/2006

Sentinel Node Biopsy Before Neoadjuvant Chemotherapy Spares Breast Cancer Patients Axillary Lymph Node Dissection

Predictors of Regional Nodal Disease in Patients With Thin Melanomas

Axillary Ultrasonography to Detect Recurrence After Sentinel Node Biopsy in Breast Cancer

Knowing When Not to Operate on Cancer: The Essence of Surgical Oncology and the Challenge for the Mentor

Fluorodeoxyglucose Positron Emission Tomography for Melanoma Staging: Refining the Indications

At the Crossroads for Retroperitoneal Sarcomas: The Future of Clinical Trials for This “Orphan Disease”